Page last updated: 2024-11-05

troglitazone and Fistula

troglitazone has been researched along with Fistula in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Fistula: Abnormal communication most commonly seen between two internal organs, or between an internal organ and the surface of the body.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hayashi, H1
Sato, Y1
Kanai, S1
Ichikawa, M1
Funakoshi, A1
Miyasaka, K1

Other Studies

1 other study available for troglitazone and Fistula

ArticleYear
Increased lymphatic lipid transport in genetically diabetic obese rats.
    American journal of physiology. Gastrointestinal and liver physiology, 2002, Volume: 282, Issue:1

    Topics: Animals; Bile Acids and Salts; Body Weight; Carrier Proteins; Chromans; Diabetes Mellitus; Diabetes

2002